TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data March 18, 2011
TCL Archive HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds March 26, 1982
TCL Archive In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal July 15, 1994
